IO Biotech, Inc. Common Stock
Symbol: IOBT (NASDAQ)
0.35
▼ (-2.78%) -0.010
Company Description:
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Key Stats
- Today's Open: $0.3656
- Today's High: $0.366
- Today's Low: $0.353
- Today's Volume: 971.60K
- Yesterday Close: $0.3631
- Yesterday High: $0.3798
- Yesterday Low: $0.3587
- Yesterday Volume: 6.58M
- Last Min Volume: 2.00K
- Last Min High: $0.355
- Last Min Low: $0.354
- Last Min VWAP: $0.35401
Company Profile
- Name: IO Biotech, Inc. Common Stock
- Website: https://www.iobiotech.com
- Listed Date: 2021-11-05
- Location: COPENHAGEN, G7
- Market Status: Active
- CIK Number: 0001865494
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $23.92M
- Round Lot: 100
- Outstanding Shares: 65.88M
- Asset Type: CS
RECENT FILINGS FOR IOBT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-29 | 8-K | View |
| 2025-08-19 | SCHEDULE 13D/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-14 | 8-K | View |
| 2025-08-11 | 8-K | View |
| 2025-07-31 | EFFECT | View |
| 2025-07-29 | CORRESP | View |
| 2025-07-29 | UPLOAD | View |
| 2025-07-24 | S-3 | View |
| 2025-06-27 | 8-K | View |
| 2025-06-20 | 8-K | View |
| 2025-06-11 | EFFECT | View |
| 2025-06-09 | CORRESP | View |
| 2025-06-09 | 8-K | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
| 2025-06-06 | 4 | View |
Latest News on IOBT